C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01) C07K 14/505 (2006.01) C07K 14/52 (2006.01) C07K 14/535 (2006.01) C07K 14/54 (2006.01) C12N 15/18 (2006.01) C12N 15/24 (2006.01) C12N 15/27 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2069746
2069746 9206116 PCTABS00011 The present invention provides recombinant hematopoietic molecules comprising at least a portion of a first hematopoietic molecule having early myeloid differentiation activity and at least a portion of a second hematopoietic molecule having late myeloid differentiation activity. Nucleic acid molecules encoding such recombinant molecules, as well as pharmaceutical compositions comprising such recombinant factors are also disclosed.
Ortho Pharmaceutical Corporation
Swabey Ogilvy Renault
LandOfFree
Hybrid growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid growth factors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2077246